In glioblastoma, we found that low ABCA1 expression in GBM patients was associated with poor DFS (P = 0.07), but the expression level of ABCA1 in GBM tumour tissues was greater than that in corresponding normal tissues (P < 0.05). The gene discussed is ABCA1; the disease is neoplasm.